Aetion

Aetion is a healthcare analytics company that delivers real-world evidence (RWE) for the manufacturers, purchasers, and regulators of medical treatments and technologies. Our customers face the critical challenge of understanding how medical interventions perform in everyday patient care, beyond the controlled environment of clinical trials. This is why we developed the Aetion Evidence Platform®, which analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. We empower biopharmaceutical companies, medical device manufacturers, payers, and regulatory agencies to make informed decisions that guide product development, commercialization, and payment innovation. Our mission is to power these critical decisions in healthcare with data science-driven technology, ultimately helping to determine what works best, for whom, and when.

Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion is built on a foundation of scientific rigor. We understand that our clients need reliable and actionable insights to navigate the complexities of the healthcare landscape. Whether it's for regulatory submissions, demonstrating value to payers, or optimizing clinical development, our platform and expert services provide the necessary tools. We work with 18 of the top 20 global pharmaceutical companies and numerous other healthcare stakeholders, helping them transform complex healthcare data into clear, dependable evidence. By fostering collaborations and leveraging advanced causal inference, rigorous epidemiologic methods, and purpose-built AI, we enable our customers to confidently address their most pressing questions and improve patient outcomes. Our vision is a world where health data is seamlessly connected and actionable, ensuring that patients receive the most effective and appropriate treatments.